AETERNUM HEALTH, INC.: 10-Q filed 2017-08-04
What AETERNUM HEALTH, INC. reported in its quarterly report filed 2017-08-04 (fiscal Q3 2017): 18 published measures, 58 facts as tagged in accession 0001144204-17-040536.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2017-08-04
- Fiscal period
- fiscal Q3 2017
- Accession
- 0001144204-17-040536 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All AETERNUM HEALTH, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-11-30 | 493 | USD | |
| At 2016-02-29 | 416 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-11-30 | 2,246,537 | USD | |
| At 2016-02-29 | 2,193,595 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-11-30 | -2,246,044 | USD | |
| At 2016-02-29 | -2,193,179 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-11-30 | 493 | USD | |
| At 2016-02-29 | 416 | USD | |
| At 2015-11-30 | 383 | USD | |
| At 2015-02-28 | 614 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-09-01 to 2016-11-30 | -14,161 | USD | 91 |
| 2016-03-01 to 2016-11-30 | -52,865 | USD | 275 |
| 2015-09-01 to 2015-11-30 | -16,610 | USD | 91 |
| 2015-03-01 to 2015-11-30 | -68,620 | USD | 275 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-11-30 | -4,930,027 | USD | |
| At 2016-02-29 | -4,877,162 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-09-01 to 2016-11-30 | 3,512,527 | shares | 91 |
| 2016-03-01 to 2016-11-30 | 3,512,527 | shares | 275 |
| 2015-09-01 to 2015-11-30 | 3,512,527 | shares | 91 |
| 2015-03-01 to 2015-11-30 | 3,512,527 | shares | 275 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-09-01 to 2016-11-30 | 3,512,527 | shares | 91 |
| 2016-03-01 to 2016-11-30 | 3,512,527 | shares | 275 |
| 2015-09-01 to 2015-11-30 | 3,512,527 | shares | 91 |
| 2015-03-01 to 2015-11-30 | 3,512,527 | shares | 275 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-09-01 to 2016-11-30 | -0.01 | USD/shares | 91 |
| 2016-03-01 to 2016-11-30 | -0.02 | USD/shares | 275 |
| 2015-09-01 to 2015-11-30 | -0.01 | USD/shares | 91 |
| 2015-03-01 to 2015-11-30 | -0.02 | USD/shares | 275 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-09-01 to 2016-11-30 | -0.01 | USD/shares | 91 |
| 2016-03-01 to 2016-11-30 | -0.02 | USD/shares | 275 |
| 2015-09-01 to 2015-11-30 | -0.01 | USD/shares | 91 |
| 2015-03-01 to 2015-11-30 | -0.02 | USD/shares | 275 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-09-01 to 2016-11-30 | 0 | USD | 91 |
| 2016-03-01 to 2016-11-30 | 0 | USD | 275 |
| 2015-09-01 to 2015-11-30 | 0 | USD | 91 |
| 2015-03-01 to 2015-11-30 | 9,391 | USD | 275 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-09-01 to 2016-11-30 | -13,857 | USD | 91 |
| 2016-03-01 to 2016-11-30 | -51,920 | USD | 275 |
| 2015-09-01 to 2015-11-30 | -16,296 | USD | 91 |
| 2015-03-01 to 2015-11-30 | -57,704 | USD | 275 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-11-30 | 493 | USD | |
| At 2016-02-29 | 416 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-09-01 to 2016-11-30 | 304 | USD | 91 |
| 2016-03-01 to 2016-11-30 | 945 | USD | 275 |
| 2015-09-01 to 2015-11-30 | 314 | USD | 91 |
| 2015-03-01 to 2015-11-30 | 1,525 | USD | 275 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-11-30 | 2,246,537 | USD | |
| At 2016-02-29 | 2,193,595 | USD |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-11-30 | 2,679,855 | USD | |
| At 2016-02-29 | 2,679,855 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-09-01 to 2016-11-30 | -14,161 | USD | 91 |
| 2016-03-01 to 2016-11-30 | -52,865 | USD | 275 |
| 2015-09-01 to 2015-11-30 | -16,610 | USD | 91 |
| 2015-03-01 to 2015-11-30 | -59,229 | USD | 275 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-09-01 to 2016-11-30 | -304 | USD | 91 |
| 2016-03-01 to 2016-11-30 | -945 | USD | 275 |
| 2015-09-01 to 2015-11-30 | -314 | USD | 91 |
| 2015-03-01 to 2015-11-30 | -1,525 | USD | 275 |
Inspect the source
- Entity
- AETERNUM HEALTH, INC. / CIK 0000764630
- Captured
- 2026-09-19T15:02:38.824Z
- SEC response SHA-256
6c9d70d4b82a4edc5f4de8082c897762179c66ba1d127e497154b6262edf21b8
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000764630.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))